US 11746109
Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate
granted A61KA61K9/485A61K9/4858
Quick answer
US patent 11746109 (Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate) held by Takeda Pharmaceutical Company Limited expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K9/485, A61K9/4858, A61P, A61P35/00